In 12 healthy volunteers the pharmacokinetic parameters of two new sustained-release formulations of disodiummonofluorophosphate (MFP) (B and C) were compared with those of a nonsustained-release reference preparation (A). This randomized study had a single-dose, triple-cross over design and consist
Studies on intranasal absorption of new formulation of 1–34 PTH in healthy volunteers
✍ Scribed by M. Nomura; T. Okuno
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- English
- Weight
- 121 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have studied the pharmacokinetics and the effects of BIM 23,014 (BIM), a new, long-acting octapeptide somatostatin analogue, on basal and stimulated GH secretion in normal men. BIM 250 micrograms sc significantly reduced a GHRH-induced increase in plasma GH. The continuous sc administration of BI
A highly sensitive and specific two-site enzyme immunoassay for parathyroid hormone (1-34) (PTH(1-34)) and its usability for the pharmacokinetic study are described. Plasma samples were incubated simultaneously with 2,4-dinitrophenylated anti-PTH(1-34) IgG and anti-PTH(1-34) Fab´β-D-galactosidase co
A procedure for the determination of a newly developed antiadhesive agent, 7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-on e (DN-9693; 1), in human plasma and urine at low nanogram levels by high-performance liquid chromatography with electrochemical detection is described. Plasma and u
This study demonstrated that a moxidectin 10 g liter À1 non-aqueous injectable formulation, injected subcutaneously in cattle at a dose of either 0.2 or 0.3 mg moxidectin kg À1 body weight was safe and highly effective in the almost complete elimination (b99% ef®cacy) for 56 days of both the nymphal